The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...

The BNP and NTproBNP market growth is driven by rising cardiovascular diseases and an aging population. Opportunities lie in ...

Dr. Sean Barbabella, offered up an official explanation for the concerning-looking rash spotted on the president's neck ...

A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress—heart muscle damage without symptoms of ...

An amyloidosis diagnosis can take upwards of 2 years.Initial symptoms often are nondescript, and irreversible organ damage frequently occurs before disease confirmation.

Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.

A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury ...

The prevalence of congenital heart disease points to the need for a better understanding of how it influences neurodevelopment. New in JNeurosci , Jung-Hoon Kim and Catherine Limperopoulos, from ...

While the strategies didn’t lower NT-proBNP after PCI in acute MI patients, they may suggest a way forward for intervening early.

The prevalence of congenital heart disease points to the need for a better understanding of how it influences ...

Recent developments of interest in cardiovascular medicine ...

The field of inflammatory response in cardiac surgery is a critical area of research due to the high morbidity and mortality associated with systemic inflammatory response (CS-SIR) evoked by on-pump ...